Texas

Immigration has been a central concern of President Donald Trump. Since taking office, his administration has put forth a number of policies to restrict the number of immigrants allowed each year, as well as from what nations those immigrants can come.

The beginning of July is when many companies increase the price on prescription medications in the U.S. This year’s price increases are higher than the same period last year.

According to a BioSpace poll, over half (56%) of respondents are not happy with their current life sciences position. Are you one of the 56%? You deserve to be happy! Start working towards your happiness and check out job opportunities at these top companies!

Have you ever asked your doctor whether the drug they are prescribing you is FDA-approved for how they are prescribing it? When a doctor prescribes an FDA-approved drug for a disease or condition, age group, or dosage other than what it has been approved for, then it is called an unapproved, or “off-label,” use.

Biotech and pharma companies tap new members of executive leadership teams and boards.

According to the poll results, 78% of respondents agree that the high costs of a gene therapy treatment are worth it, due to the fact that these options are seen as potential cures for disease.

Last week there were quite a few clinical trials whose data were presented. Many were at the American Diabetes Association 79th Scientific Sessions, while others were presented at separate meetings or independently. Here’s a look.

Biotech and pharma companies strengthen their leadership teams and boards with new hires and appointments.

Texas-based Savara tried to put a positive spin on the trial and pointed to positive secondary endpoints but it wasn’t enough to please investors.

Here’s a look at some of last week’s clinical trial announcements, including some from the American Society of Clinical Oncology Annual Meeting you might have missed.